Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Wing

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Immunology|March 1, 1995
The molecular basis for a polyspecific antibodyM G Wing
Environmental Management|January 10, 2001
Quantifying forest visibility with spatial dataM G Wing, R Johnson
Alternatives to Laboratory Animals : ATLA|December 6, 2000
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical developmentC K Atterwill, M G Wing
Neuroreport|April 10, 1996
CD59 expression and complement susceptibility of human neuronal cell line (NTera2)C Agoropoulou, M G Wing, A Wood
The European Journal of Neuroscience|March 27, 2001
Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa BR S Nicholas, M G Wing, A Compston
Nature Biotechnology|July 1, 1997
Complement recruitment using bispecific diabodiesR E Kontermann, M G Wing, G Winter
Immunology|February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugateA M Montgomery, M G Wing, P J Lachmann
Clinical and Experimental Immunology|November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugatesA M Montgomery, M G Wing, P J Lachmann
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapyA J Coles, M G Wing, D A Compston
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Characterisation of suppressor cells generated following cryosurgery of an HSV-2-induced fibrosarcomaM G Wing, K Rogers, G Jacob, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Immunology|March 1, 1995
The molecular basis for a polyspecific antibodyM G Wing
Environmental Management|January 10, 2001
Quantifying forest visibility with spatial dataM G Wing, R Johnson
Alternatives to Laboratory Animals : ATLA|December 6, 2000
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical developmentC K Atterwill, M G Wing
Neuroreport|April 10, 1996
CD59 expression and complement susceptibility of human neuronal cell line (NTera2)C Agoropoulou, M G Wing, A Wood
The European Journal of Neuroscience|March 27, 2001
Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa BR S Nicholas, M G Wing, A Compston
Nature Biotechnology|July 1, 1997
Complement recruitment using bispecific diabodiesR E Kontermann, M G Wing, G Winter
Immunology|February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugateA M Montgomery, M G Wing, P J Lachmann
Clinical and Experimental Immunology|November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugatesA M Montgomery, M G Wing, P J Lachmann
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapyA J Coles, M G Wing, D A Compston
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Characterisation of suppressor cells generated following cryosurgery of an HSV-2-induced fibrosarcomaM G Wing, K Rogers, G Jacob, et al.
Pageof 3